Adaptive Biotechnologies Corporation (ADPT)
NASDAQ · Healthcare
Adaptive Biotechnologies Corporation Operating Income 2017–2025
Adaptive Biotechnologies Corporation annual/quarterly operating income history and growth rate from 2017 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Adaptive Biotechnologies Corporation operating income for the quarter ending March 31, 2026 was -19.2 M, a 35.12% decrease year-over-year.
- Adaptive Biotechnologies Corporation operating income for the twelve months ending March 31, 2026 was -63.6 M, a 64.63% decrease year-over-year.
- Adaptive Biotechnologies Corporation annual operating income for 2025 was -57.1 M, a 64.86% decrease from 2024.
- Adaptive Biotechnologies Corporation annual operating income for 2024 was -162.5 M, a 28.40% decrease from 2023.
- Adaptive Biotechnologies Corporation annual operating income for 2023 was -227.0 M, a 13.41% increase from 2022.
- Adaptive Biotechnologies Corporation annual operating income for 2022 was -200.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Adaptive Biotechnologies Corporation Operating Income — FAQ
Adaptive Biotechnologies Corporation (ADPT) operating income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Adaptive Biotechnologies Corporation's operating income?
Adaptive Biotechnologies Corporation (ADPT) reported operating income of -$57M for fiscal 2025.
Where can I see ADPT's operating income history?
The chart and table above show Adaptive Biotechnologies Corporation's operating income by year and by quarter, including the growth rate.